Literature DB >> 18386916

Chemical fragments as foundations for understanding target space and activity prediction.

Jeffrey J Sutherland1, Richard E Higgs, Ian Watson, Michal Vieth.   

Abstract

The use of small inhibitors' fragment frequencies for understanding kinase potency and selectivity is described. By quantification of differences in the frequency of occurrence of fragments, similarities between small molecules and their targets can be determined. Naive Bayes models employing fragments provide highly interpretable and reliable means for predicting potency in individual kinases, as demonstrated in retrospective tests and prospective selections that were subsequently screened. Statistical corrections for prospective validation allowed us to accurately estimate success rates in the prospective experiment. Selectivity relationships between kinase targets are substantially explained by differences in the fragment composition of actives. By application of fragment similarities to the broader proteome, it is shown that targets related by sequence exhibit similar fragment preferences in small molecules. Of greater interest, certain targets unrelated by sequence are shown to have similar fragment preferences, even when the chemical similarity of ligands active at each target is low.

Mesh:

Substances:

Year:  2008        PMID: 18386916     DOI: 10.1021/jm701399f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Computational Modeling of Kinase Inhibitor Selectivity.

Authors:  Govindan Subramanian; Manish Sud
Journal:  ACS Med Chem Lett       Date:  2010-07-28       Impact factor: 4.345

3.  Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.

Authors:  Lars Neumann; Allegra Ritscher; Gerhard Müller; Doris Hafenbradl
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

4.  Structural and Activity Profile Relationships Between Drug Scaffolds.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2015-02-20       Impact factor: 4.009

5.  Many approved drugs have bioactive analogs with different target annotations.

Authors:  Ye Hu; Eugen Lounkine; Jürgen Bajorath
Journal:  AAPS J       Date:  2014-05-29       Impact factor: 4.009

6.  Kinome-wide activity modeling from diverse public high-quality data sets.

Authors:  Stephan C Schürer; Steven M Muskal
Journal:  J Chem Inf Model       Date:  2013-01-09       Impact factor: 4.956

7.  Are phylogenetic trees suitable for chemogenomics analyses of bioactivity data sets: the importance of shared active compounds and choosing a suitable data embedding method, as exemplified on Kinases.

Authors:  Shardul Paricharak; Tom Klenka; Martin Augustin; Umesh A Patel; Andreas Bender
Journal:  J Cheminform       Date:  2013-12-13       Impact factor: 5.514

8.  Distributed Representation of Chemical Fragments.

Authors:  Suman K Chakravarti
Journal:  ACS Omega       Date:  2018-03-08

9.  Descriptor Free QSAR Modeling Using Deep Learning With Long Short-Term Memory Neural Networks.

Authors:  Suman K Chakravarti; Sai Radha Mani Alla
Journal:  Front Artif Intell       Date:  2019-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.